CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

CTNNB1 / β-catenin pathway (desmoid tumor)

Gene: CTNNB1 · Type: mutation

Indications: Desmoid tumor

SensitivityResistanceCIViC Context

FDA Sensitivity Assertions

DrugIndicationRecommendationFDA SourceLink
NirogacestatDesmoid tumorINDICATED
FDA Label
Label